Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine Conditioning for AlloSCT in Pediatric Leukemia
NCT00529360Phase 2Completed
- Sponsor
- New York Medical College
- Start
- Jun 2007
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by New York Medical College. Started Jun 2007; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00529360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529360.